Dowpharma signs agreement with Japanese distributor
Dowpharma, part of The Dow Chemical Company's Custom & Fine Chemicals global business unit, has signed an agreement with CBC Co. Ltd, of Tokyo, Japan, to market Dow's pharmaceutical services to Japanese drug makers.
Dowpharma, part of The Dow Chemical Company's Custom & Fine Chemicals global business unit, has signed an agreement with CBC Co. Ltd, of Tokyo, Japan, to market Dow's pharmaceutical services to Japanese drug makers.
The agreement arises out of an existing relationship that CBC had with Chirotech, which was part of the Ascot acquisition that Dow made in 2001 and now part of the Dowpharma business.
The Japanese government recently made it legal for pharmaceutical companies to outsource the manufacture of APIs, and Dowpharma believes its extensive toolbox of enabling technologies, including a wide selection of industrially ready chiral technologies, puts it in a strong position to take advantage of the change.
'We see growth opportunities, as Japan is one of the largest pharmaceutical markets and will need contract manufacturing organisations that can support a wide range of offerings/services along with customised solutions,' said Gwin Bompas, Dowpharma commercial director for Europe and Asia/Japan.
CBC will also assist Dowpharma in obtaining technology licenses from identified Japanese authorities and companies.